VISIRNA THERAPEUTICS
Visirna Therapeutics to develop and commercialize RNAi therapeutics targeting cardiovascular and metabolic diseases.
VISIRNA THERAPEUTICS
Industry:
Biotechnology Health Care Medical Therapeutics
Address:
Shanghai, Shanghai, China
Country:
China
Status:
Active
Total Funding:
60 M USD
Current Advisors List
Investors List
Vivo Capital
Vivo Capital investment in Seed Round - Visirna Therapeutics